- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06434727
Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures. (ISI-I3DM-01)
February 27, 2026 updated by: Intuitive Surgical
A Retrospective Multicenter Study for Intuitive 3D Models (I3DM), During Simulated Preoperative Surgical Planning for Anatomic Lung Resection and Lower Anterior Resection Procedures
The Study Objective: To evaluate the clinical utility of a 3D model with 2D CT/MRI scans during simulated preoperative surgical planning of open, laparoscopic, or robotic-assisted anatomic lung resection (segmentectomy, lobectomy) or Lower Anterior Resection (LAR) procedures.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a Retrospective study evaluating the clinical utility of a 3D model with 2D CT/MRI scans during simulated preoperative surgical planning of open, laparoscopic, or robotic-assisted anatomic lung resection (segmentectomy, lobectomy) or Lower Anterior Resection (LAR) procedures.
Study Type
Observational
Enrollment (Actual)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Our Lady of the Lake Regional Medical Center
-
-
New York
-
Manhasset, New York, United States, 11030
- The Feinstein Institutes for Medical Research
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Utah
-
Salt Lake City, Utah, United States, 84112
- University of Utah
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Subjects 18 years or older who have undergone either anatomic lung resection (segmentectomy, lobectomy) or a Lower Anterior Resection procedure will be considered for this study.
Description
Inclusion Criteria:
- DICOM images from Subjects 18 years or older who have undergone either anatomic lung resection (segmentectomy, lobectomy) or a Lower Anterior Resection procedure
Exclusion Criteria:
- N/A
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Thoracic Group
Anatomic Lung Resection (Segmentectomy or Lobectomy) Procedures
|
Observational Study
|
|
Colorectal Group
Lower Anterior Resection Procedures
|
Observational Study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Utility of 3D Model vs standard 2D in Preoperative Surgcial Planning
Time Frame: 2 months
|
Surgeon questionnaires evaluating their preoperative surgical plan
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2024
Primary Completion (Actual)
November 9, 2025
Study Completion (Actual)
November 9, 2025
Study Registration Dates
First Submitted
May 23, 2024
First Submitted That Met QC Criteria
May 23, 2024
First Posted (Actual)
May 30, 2024
Study Record Updates
Last Update Posted (Actual)
March 3, 2026
Last Update Submitted That Met QC Criteria
February 27, 2026
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISI-I3DM-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Disorders
-
Gulhane School of MedicineUniversity Hospital, Ghent; Szeged University; University Clinical Centre of... and other collaboratorsCompletedColorectal Disorders | Colorectal SurgeryTurkey
-
Institut Paoli-CalmettesNot yet recruitingColorectal Disorders
-
Leonardo Bustamante-LopezRodrigo Ambar PintoUnknownColorectal DisordersBrazil
-
Katherine DeansSociety of University SurgeonsCompleted
-
Mayo ClinicCompleted
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Mount Sinai Hospital, CanadaRecruiting
-
Joanne TurnerCompletedColorectal DisordersUnited Kingdom
-
Hospital Universitario La FeUnknown
-
Barts & The London NHS TrustCompletedColorectal DisordersUnited Kingdom
Clinical Trials on observational study
-
Taysha Gene Therapies, Inc.Withdrawn
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
Drexel UniversityCompletedOsteoporosisUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Roswell Park Cancer InstituteRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Children's Oncology GroupNot yet recruitingChildhood Hematopoietic and Lymphatic System Neoplasm | Childhood Malignant Solid Neoplasm
-
Ohio State University Comprehensive Cancer CenterAmerican Association for Cancer ResearchRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingEndometrial CarcinomaUnited States